PTA

Following the results of the ANI technology (Analgesia Nociception Index) on the monitoring of non-communicating patients, an adaptation of the algorithm was performed to develop the PTA index (Parasympathetic Tone Activity). The PTA technology enables the evaluation of the parasympathetic part of the autonomic nervous system of animals

The first parasympathetic tone monitoring device in the world for pets

Veterinarians face a challenge when it comes to assessing animal’s surgical stress during surgery due to the absences of clear physiological signs. That’s why we developed a heart rate variability analysis device simple of use, not operator-dependent, based on the acquisition of electrocardiographic (ECG) signal.

The PTA index provides an objective value to veterinarians to evaluate analgesia. The monitor offers a value between 0 and 100 corresponding to the percentage of activity of the parasympathetic part of the Autonomous Nervous System of the animal. The higher the value of the PTA index is the higher the animal’s comfort.

Monitor ANI V1

Monitor ANI V2

ANI MOC-9

Version V1 V2 V1
Documents Product brochure V1 (EN) Product brochure V2 (EN)
Product brochure V2 (FR)
Product brochure V1 (EN)
User Manual User Manual User Manual User Manual

Testimonials

Our technology is used by top physicians around the world

Miguel Angel Cabezas

In my opinion, the inclusion of PTA in the monitoring protocol allows us to complete the information and refine the treatment in something as complicated as nociception, thinking not only intraoperatively but also in postoperative pain.

Miguel Angel Cabezas

Head of the Anesthesia at Hospital Veterinario Puchol, Madrid

Ignacio Álvarez Gómez de Segura

Currently, the clinical assessment method for nociception (intraoperative ‘pain’) is based on simple but basic responses, such as sudden increases in heart and respiratory rates or blood pressure. These responses imply that we are late in providing a good pain reliever and stability plan for our patients. The PTA monitor is a novel approach and a significant advance to detect the presence of nociception, and to anticipate situations where our patients do not have sufficient analgesic coverage.

Ignacio Álvarez Gómez de Segura

Chef of the Anesthesiology department at Universidad Complutense de Madrid 

Scientific Evidences

Clinical studies

  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “MDoloris capte les douleurs muettes” – Les Echos 121 / LEARN MORE
  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “C’est la première fois qu’on mesure la douleur” – La Voix du Nord/ LEARN MORE

Case reports

  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “MDoloris capte les douleurs muettes” – Les Echos 121 / LEARN MORE
  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “C’est la première fois qu’on mesure la douleur” – La Voix du Nord/ LEARN MORE
  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “MDoloris capte les douleurs muettes” – Les Echos 121 / LEARN MORE
  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “C’est la première fois qu’on mesure la douleur” – La Voix du Nord/ LEARN MORE

Publications

  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “MDoloris capte les douleurs muettes” – Les Echos 121 / LEARN MORE
  • Obtention du prix “Entrepreneur de l’année 2014, Born Global” – l’Express / LEARN MORE
  • “C’est la première fois qu’on mesure la douleur” – La Voix du Nord/ LEARN MORE

Videos

Presentation about the PTA (Parasympathetic Tone Activity)